|
BAT2L1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.104700E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.886460E-02 |
| Normal-vs-Stage2 |
1.771580E-01 |
| Normal-vs-Stage3 |
2.422200E-04 |
| Normal-vs-Stage4 |
9.61800000000013E-05 |
| Stage1-vs-Stage2 |
6.353200E-01 |
| Stage1-vs-Stage3 |
6.847800E-02 |
| Stage1-vs-Stage4 |
1.827770E-02 |
| Stage2-vs-Stage3 |
1.277620E-01 |
| Stage2-vs-Stage4 |
5.559900E-02 |
| Stage3-vs-Stage4 |
5.149000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.840900E-03 |
| Normal-vs-AfricanAmerican |
2.603600E-01 |
| Normal-vs-Asian |
1.831690E-02 |
| Caucasian-vs-AfricanAmerican |
4.408800E-01 |
| Caucasian-vs-Asian |
9.981200E-01 |
| AfricanAmerican-vs-Asian |
4.727800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.119840E-03 |
| Normal-vs-Female |
7.461400E-03 |
| Male-vs-Female |
3.436200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.727800E-02 |
| Normal-vs-Age(41-60Yrs) |
3.804800E-03 |
| Normal-vs-Age(61-80Yrs) |
3.384400E-04 |
| Normal-vs-Age(81-100Yrs) |
3.249600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.979800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.978000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.568400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.140600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.483800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.802800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.578260E-03 |
| Classical-VS-Follicular |
7.088200E-02 |
| Classical-VS-Other |
8.113800E-02 |
| Classical-VS-Normal |
3.734300E-02 |
| Tall-VS-Follicular |
1.412430E-01 |
| Tall-VS-Other |
6.391200E-01 |
| Tall-VS-Normal |
8.39220000000696E-05 |
| Follicular-VS-Other |
3.130800E-01 |
| Follicular-VS-Normal |
3.722300E-03 |
| Other-VS-Normal |
9.101700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.058410E-02 |
| Normal-vs-N1 |
3.563000E-04 |
| N0-vs-N1 |
8.676100E-02 |
|
|
